Seven of them had androgen-insensitivity syndrome (AIS), a condition in which a genetic male is resistant to androgens, the male sex hormones that include testosterone.
If the genes order the gonads to become testicles and put out the male hormone androgen, the embryo will turn into a boy; otherwise it becomes a girl.
Antiandrogen drugs, like bicalutamide, work by binding to the androgen receptors on prostate-cancer cells, chemically preventing the hormones from interacting with the tumor.
Research and Markets: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline ... DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bchwdq/hormone) has announced the addition of the "Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2013" report to their offering. Global Markets Direct's, 'Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline ...
June 5, 2013 - Business Wire